Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Chris Mok and Huibin Lv.
Chris Mok
Connection Strength
3.828
Huibin Lv
  1. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
    View in: PubMed
    Score: 0.952
  2. COVID-19 vaccines: Knowing the unknown. Eur J Immunol. 2020 07; 50(7):939-943.
    View in: PubMed
    Score: 0.889
  3. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.883
  4. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.883
  5. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
    View in: PubMed
    Score: 0.057
  6. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020 09 04; 369(6508):1210-1220.
    View in: PubMed
    Score: 0.056
  7. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020 05 08; 368(6491):630-633.
    View in: PubMed
    Score: 0.055
  8. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.